Paul Cowan: Executive Chairman
Paul founded Quotient in 2007 following the acquisition of Alba Bioscience. Has has broad healthcare industry experience gained over 15+ years working in industry and in investment banking. Prior to founding Quotient, Paul was the CFO of Inveresk Research Group, a major pre-clinical contract research organisation acquired by Charles River Laboratories in 2004. Prior to that he was a senior executive with Bear Stearns (heading up its European biotechnology practice) and Deutsche Morgan Grenfell.
Jeremy Stackawitz: President & CEO
Jeremy has 15 years in healthcare including diagnostics, pharmaceutical and biotechnology. His past experiences include former Commercial Director of Immunohematology, Ortho Clinical Diagnostics, Johnson & Johnson and former Strategy Consultant to healthcare industry with Monitor and McKinsey & Co consultancies.
Michael Hannan: EVP, Commercial Operations
Mick has 20 years healthcare experience in a variety of settings. His past experience includes leadership roles with GlaxoSmithKline in the areas of acquisitions, marketing, sales, business development and business analytics; former Senior Strategy Consultant to healthcare industry with Monitor Consulting, and former Healthcare Analyst for Dow Jones & Co.
John Allan: Managing Director, Supply & Operations
John has 30 years experience in diagnostics and extensive knowledge of the global blood bank market. John spent 15 years working in Hospital & Transfusion Service Laboratories in the UK and Middle East, until moving into diagnostic reagent manufacturing in 1990. John was a Board Member at Scottish National Blood Transfusion Service from 1999 until 2007, Chairperson at EDMA Blood Typing Working Party from 1997 until 2007, a member of the EDMA representative to European Commission IVD Expert Group from 2001 until 2007, and a member of the UKBTS Reagents Standing Advisory Committee from 1994 until 2007.
Bill Brady: Vice President, Sales
Bill Brady has 30 years of transfusion products experience. He has held various senior management positions, most recently with Charter Medical, as Business Development Director for the Medical Filtration and Transfusion Therapy business, and Baxter Healthcare’s Fenwal Division of North America, as an Area Vice President.